Today: 16 April 2026
L’Oreal share price slips into weekend as OR.PA heads for annual results test
7 February 2026
1 min read

L’Oreal share price slips into weekend as OR.PA heads for annual results test

Paris, Feb 7, 2026, 22:06 (CET) — The session has ended for the Paris market.

  • L’Oréal (OREP.PA) slipped 0.16% on Friday, finishing the session at 394.05 euros.
  • The group plans to release its 2025 annual results after the bell on Feb. 12, with a financial information meeting lined up for Feb. 13, according to its calendar.

L’Oréal S.A. slipped to 394.05 euros by Friday’s close, traders stepping back ahead of the French cosmetics giant’s annual results set for early next week.

Paris trading picks up again Monday. Positioning can turn choppy before major releases, particularly in heavyweight “defensive” consumer stocks—popular with funds looking for some stability.

Europe’s earnings season is all over the map—still, investors keep hunting for clear reads on pricing and demand at the continent’s exporters. According to LSEG I/B/E/S data cited by Reuters, analysts are sticking with predictions for a drop in fourth-quarter 2025 earnings on the STOXX 600, despite most results to date beating expectations.

L’Oréal dropped for a second day, down 1.18% Thursday. During Friday’s session, shares moved in a band between 385.70 and 395.10 euros. Roughly 319,000 shares traded hands, per Investing.com data.

There was little sign of strain in the broader market on Friday. The STOXX 600 added 0.9% to close at 617.12, tallying a 1% gain for the week, Reuters reported. That move came despite a sharp drop in Stellantis and tech logging their steepest weekly slide in almost three months. “In the U.S., they are seeing a dislocation between software and hardware, driven by an AI theme,” said Sophie Huynh, portfolio manager and strategist at BNP Paribas Asset Management. Reuters

L’Oréal’s immediate story isn’t really about the day-to-day share moves—it’s what executives reveal about demand looking toward 2026. Investors zero in on North America and China momentum, watch for hints of discounting, and scrutinize whether ramped-up marketing or new launches are actually driving units, not just price tags.

Timing isn’t trivial here, with major European consumer exporters set to report in a similar window. Next week brings numbers from Hermès and EssilorLuxottica—both on deck—which could steer how investors read broader discretionary spend and the pulse of travel-related demand.

L’Oréal ended Friday trading close to the high of its 52-week span, which runs from 326.65 to 408.35 euros, and its market capitalization hovered near 210 billion euros, according to Morningstar data.

That knife swings both ways. If a stock’s sitting close to its highs, even a modest sales miss or some hedging on margins can send it tumbling harder than the usual daily dip might show.

Trading picks up again in Paris on Monday. The trigger: annual results, which dropped after Thursday’s close, plus a follow-up meeting on Friday. That’s when analysts are likely to push for more color on regional performance and what’s on deck for 2026.

Stock Market Today

  • Theravance Biopharma Shares Drop 17% After Phase III Trial Failure and Organizational Restructuring
    April 16, 2026, 3:11 PM EDT. Theravance Biopharma (TBPH) stock has fallen nearly 17% over three months, trailing the biotech industry's 2.2% growth. The decline follows the failure of its major Phase III CYPRESS study for ampreloxetine, a drug aimed at treating neurogenic orthostatic hypotension. The trial did not meet its primary endpoint, prompting Theravance to halt the drug's development. This setback has weakened the company's pipeline and revenue outlook. In response, Theravance launched a strategic review, including potential company sale, and plans to reduce its workforce by about 50%, cutting its research and administrative staff. The company currently relies heavily on collaboration revenues, with no wholly owned commercial product, increasing investor uncertainty.

Latest article

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Intel Launches Lower-Cost 18A PC Chips as Analysts Lift Targets Ahead of Earnings

Intel Launches Lower-Cost 18A PC Chips as Analysts Lift Targets Ahead of Earnings

16 April 2026
Intel launched its Core Series 3 mobile processors Thursday, bringing its 18A chipmaking process to mainstream laptops and edge systems. Shares rose 4.2% to $67.69 after the announcement. More than 70 device designs from partners including Acer, HP, and Samsung are expected in coming months. Wall Street raised price targets but some analysts cautioned about ongoing challenges and competition from AMD and TSMC.
IonQ Stock Extends Rally After DARPA Win and Quantum Networking Breakthrough

IonQ Stock Extends Rally After DARPA Win and Quantum Networking Breakthrough

16 April 2026
IonQ shares climbed 2.8% to $44.46 by midday Thursday after announcing a DARPA contract under the new HARQ program and linking two commercial quantum systems with photons. The company reported 2025 revenue of $130 million and projected up to $245 million for 2026. Peers Rigetti and D-Wave Quantum also gained after Nvidia launched new AI models for quantum calibration and error correction.
IBM stock price jumps 3% into weekend as Confluent vote and dividend date near
Previous Story

IBM stock price jumps 3% into weekend as Confluent vote and dividend date near

CATL stock price rises after sodium-ion EV push; what investors watch before Shenzhen reopens
Next Story

CATL stock price rises after sodium-ion EV push; what investors watch before Shenzhen reopens

Go toTop